X

Drug Profile

RD 1303

Alternative Names: RD-1303

Latest Information Update: 16 Sep 2024

Price : $50 ^*

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator PharmGen Science
Class Gadolinium-containing contrast agents; Macrocyclic compounds
Mechanism of Action Magnetic resonance imaging enhancers

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

Highest Development Phases

Preclinical Digestive system disorders

Most Recent Events

18 May 2024 Preclinical trials in Digestive system disorders (Diagnosis) in South Korea (IV), prior to May 2024
18 May 2024 Pharmacodynamics data from a preclinical trial in Digestive system disorders presented at the Digestive Disease Week 2024 (DDW-2024)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com